To investigate the role of CD4+ and CD8+ T-cell subsets in anti-tumor activity, we evaluated the specific lysis capacity of the CAR-T cells via co-cultivation with GFP + CD20+ Raji cells in an effector to target ratio (E:T) of 1:1. The gene discussed is CD8A; the disease is neoplasm.